Hedysarum multijugum Maxim treats ulcerative colitis through the PI3K-AKT and TNF signaling pathway according to network pharmacology and molecular docking

BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) that prevails mainly in western countries. Due to the unknown etiology of UC, the purpose of treatments has predominantly comprised symptomatic and pain relief. With extensive research focusing on the pathogenesis of U...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zihao, Chong, Wei, Xie, Xiaozhou, Liu, Yuan, Shang, Liang, Li, Leping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652569/
https://www.ncbi.nlm.nih.gov/pubmed/36388782
http://dx.doi.org/10.21037/atm-22-4815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652569/
https://www.ncbi.nlm.nih.gov/pubmed/36388782
http://dx.doi.org/10.21037/atm-22-4815

Ejemplares similares